Prostate Cancer Diagnostic Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Veröffentlicht von: precision business insights
Veröffentlicht am: 09.04.2018 13:12
Rubrik: Gesundheit & Medizin


(Presseportal openBroadcast) - Prostate Cancer Diagnostic Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Pressekontakt:

Prostate Cancer Diagnostic Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024
Market Outline: Prostate Cancer Diagnostic Market
Prostate cancer is the most common type of cancer in men it is characterized by the abnormal development of cells in prostate gland and it may extent in the surrounding parts of prostate gland. Prostate cancer diagnostics market is classified on the basis of product type, age, cancer stage, and geography. Prostate cancer is age dependent cancer risk of prostate cancer increases with increase in age, family history, chemical exposure, smoking, inflammation of prostate and infections are other risk factors for prostate cancer.

Market Dynamics: Prostate Cancer Diagnostic Market
Increase in prostate cancer awareness, lifestyle changes and technological advances are boosting the prostate cancer diagnostic market. Diagnosis and treatment available for prostate cancer are expensive and are associated with several side effects like urinary incontinence, surgical risks like stroke, heart attack, blood clots, which may hinder the prostate cancer diagnostic market over the forecasted period.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/prostate-cancer-diagnostic-market/#ulp-4H8Z4LpNMLEuOnnx


Market Scope: Prostate Cancer Diagnostic Market
By Test Type
• Tumor Biomarker Tests
• Imaging
• Biopsy
• Other
By Cancer Stage
• Stage I
• Stage II A
• Stage II B
• Stage III
• Stage IV
By End User
• Hospital Associated Labs
• Independent Diagnostic Labs
• Diagnostic Imaging Centers
• Cancer Research Institutes
• Others

Market Summary: Prostate Cancer Diagnostic Market
Prostate cancer diagnostic market is expected to show significant growth over the forecast period owing to increasing prevalence of prostate cancer and technological advancements. Biopsy is expected to be dominant diagnostic tool in prostate cancer diagnosis as it is mandatory to determine the presence of cancerous lump and cause of high level of prostate-specific antigen (PSA). Imagining prostate cancer diagnostic is expected to rise in forecasted period due to technological advances in the imaging such as a newer approach to measure blood flow within the gland using a technique called color droppler ultrasound. It detects tumor more accurately. ConfirmMDx is advanced diagnosis method which is a test that looks at certain genes in the cells from a prostate biopsy sample for accurate diagnosis. Multi parametric MRI is a newer technique that can be used to help determine the extent of the cancer and how severe it might be.


To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/prostate-cancer-diagnostic-market/#ulp-c654SbFYO64MsOhu


Regional Analysis: Prostate Cancer Diagnostic Market
Prostate cancer diagnostics market is classified on the basis of geography in to North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. USA along with other developed countries captures major market revenues in prostate cancer diagnosis market due to growing prevalence and incidences of prostate cancer. Asia Pacific and Africa expected to offer potential to grow in forecasted period due to increase in risk factors and awareness of prostate cancer.

Competition Assessment: Prostate Cancer Diagnostic Market
• Abbott Laboratories
• OPKO
• Siemens Healthcare
• DiaSorin
• BioMeriux
• Roche
• MDx Health
• Beckman Coulter
• Myriad Genetics
• Ambry Genetics
• Genomic Health

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/prostate-cancer-diagnostic-market/#ulp-14mlyhjMGhVjZqa3

Key Features of the Report:
• The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/prostate-cancer-diagnostic-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com


Bitte beachten Sie, dass für den Inhalt der hier veröffentlichten Meldung nicht openBroadcast verantwortlich ist, sondern der Verfasser der jeweiligen Meldung selbst. AGB | Haftungsausschluss.